Translation and Validation of the King's Brief Interstitial Lung Disease Questionnaire in Hindi Language
- PMID: 40836721
- DOI: 10.59556/japi.73.1043
Translation and Validation of the King's Brief Interstitial Lung Disease Questionnaire in Hindi Language
Abstract
Aims and background: The King's Brief Interstitial Lung Disease (K-BILD) questionnaire, used to evaluate health-related quality of life (HRQoL) in interstitial lung diseases (ILDs), has been translated and validated in multiple languages. However, there is currently no validated Hindi translation available.
Methods: This study aimed to translate and validate the K-BILD questionnaire into Hindi for ILD patients. Using a forward-backward translation method after approval from the original developers, we created the Hindi version and provided it to patients alongside the St George's Respiratory Questionnaire (SGRQ). We evaluated the Hindi K-BILD's reliability and validity by examining internal consistency, concurrent validity, and effect size (ES).
Results: About 86 patients completed the Hindi version of the K-BILD questionnaire, demonstrating good internal consistency in the total score, breathlessness and activities, and psychological domains (Cronbach's α = 0.939, 0.916, and 0.928, respectively) and acceptable consistency in the chest symptoms domain (Cronbach's α = 0.732). Concurrent validity with the SGRQ domains and total scores was strong to very strong (p < 0.001). The K-BILD score also distinguished disease severity, notably in forced vital capacity (FVC) Z score (0.257) and diffusion capacity of lung for carbon monoxide (DLCO) Z score (0.181).
Conclusion: The Hindi language-translated K-BILD questionnaire was well accepted by patients and showed excellent validity, comparable to the original version of K-BILD in English language.
Clinical significance: The validated Hindi K-BILD enhances patient care, communication, and research for Hindi-speaking ILD patients by providing a reliable, culturally relevant tool for assessing health status and disease severity.
© Journal of The Association of Physicians of India 2025.
Similar articles
-
Translation and validation of the King's Brief Interstitial Lung Disease (K-BILD) questionnaire in French, Italian, Swedish, and Dutch.Chron Respir Dis. 2017 May;14(2):140-150. doi: 10.1177/1479972316674425. Epub 2016 Dec 26. Chron Respir Dis. 2017. PMID: 28019103 Free PMC article.
-
Patient-reported outcome measures for cough used in interstitial lung disease: a systematic review.Eur Respir Rev. 2025 Jul 9;34(177):240206. doi: 10.1183/16000617.0206-2024. Print 2025 Jul. Eur Respir Rev. 2025. PMID: 40633974 Free PMC article.
-
Pulmonary rehabilitation for interstitial lung disease.Cochrane Database Syst Rev. 2021 Feb 1;2(2):CD006322. doi: 10.1002/14651858.CD006322.pub4. Cochrane Database Syst Rev. 2021. PMID: 34559419 Free PMC article.
-
The development and validation of the King's Brief Interstitial Lung Disease (K-BILD) health status questionnaire.Thorax. 2012 Sep;67(9):804-10. doi: 10.1136/thoraxjnl-2012-201581. Epub 2012 May 3. Thorax. 2012. PMID: 22555278
-
Psychometric validation and interpretation thresholds of the Hidradenitis Suppurativa Quality of Life (HiSQOL©) questionnaire using pooled data from the phase III BE HEARD I & II trials of bimekizumab in hidradenitis suppurativa.Br J Dermatol. 2025 Jun 20;193(1):93-104. doi: 10.1093/bjd/ljaf067. Br J Dermatol. 2025. PMID: 40172122 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Medical